Abdelmalik Slassi
Vermogen: 79 500 $ op 30-09-2026
Vermogen: 79 500 $ op 30-09-2026
Abdelmalik Slassi was the founder of Mindset Pharma, Inc., founded in 2019, holding the title of Senior Vice President-Innovation.
Dr. Slassi is also the founder of Fluorinov Pharma, Inc...
Dr. Slassi is currently Director at Pharmala Biotech, Inc. Former positions include Director & Vice President-Medicinal Chemistry at NPS Pharmaceuticals, Inc., Independent Director at Pharmala Biotech Holdings, Inc. from 2021 to 2026, Director & VP-Manufacturing & Drug Development at Cascade Therapeutics, Inc., and Senior Vice President-Drug Discovery Research at Trillium Therapeutics, Inc. from 2016 to 2019.
Education includes a doctorate from Université Claude Bernard Lyon 1.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-05-2025 | 500.000 ( 0,46% ) | 79 500 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Bestuurslid | 09-02-2026 |
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 01-12-2019 |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Oprichter | 01-01-2016 |
| MINDSET PHARMA INC. | Oprichter | - |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Commercial Services |
Mindset Pharma, Inc.
Mindset Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for psychiatric and neurological disorders | Health Technology |
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau